ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,502Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 617

$720K Total Retail Price of All Prescriptions

Rank: 25 out of 617

371 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 371 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 371 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 9,284 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
HYDROCODONE-ACETAMINOPHEN 761 311 S3 1 8
SIMVASTATIN 549 444 2 2
LEVOTHYROXINE SODIUM 359 268 3 1
FUROSEMIDE 353 258 4 4
OMEPRAZOLE 347 298 5 3
METOPROLOL TARTRATE 347 261 5 11
GABAPENTIN 284 176 7 16
WARFARIN SODIUM 262 201 8 7
DICLOFENAC SODIUM 250 149 9 98
LISINOPRIL 248 202 10 5
CITALOPRAM HBR 218 140 11 18
METOPROLOL SUCCINATE 217 191 12 12
POTASSIUM CHLORIDE 207 146 13 10
ZOLPIDEM TARTRATE 179 64 14 23
AMLODIPINE BESYLATE 170 125 15 6
TRAZODONE HCL 167 99 16 51
OXYCODONE HCL 166 0 S2 17 130
METFORMIN HCL 157 83 18 9
TRAMADOL HCL 149 112 19 15
ENALAPRIL MALEATE 128 79 20 34
HYDROCHLOROTHIAZIDE 126 80 21 13
ALLOPURINOL 123 84 22 27
CARVEDILOL 106 98 23 19
ATORVASTATIN CALCIUM 105 90 24 14
PREDNISONE 105 82 24 31
CRESTOR 105 92 24 28
PRAVASTATIN SODIUM 104 92 27 21
CARISOPRODOL 102 0 R 28 178
ALENDRONATE SODIUM 100 74 29 25
BACLOFEN 99 40 30 146
LOSARTAN POTASSIUM 97 89 31 22
TORSEMIDE 97 79 31 110
PROAIR HFA 96 47 33 75
NABUMETONE 94 49 34 120
DOXYCYCLINE HYCLATE 94 64 34 113
DONEPEZIL HCL 93 93 36 30
BENAZEPRIL HCL 92 67 37 44
ADVAIR DISKUS 91 38 38 38
ATENOLOL 83 59 39 17
OXYCODONE-ACETAMINOPHEN 81 60 S2 40 93
RANITIDINE HCL 81 41 40 40
ENDOCET 79 12 S2 42 182
PANTOPRAZOLE SODIUM 79 60 42 37
GLYBURIDE 78 57 R 44 84
VENLAFAXINE HCL 77 23 45 223
DOXEPIN HCL 76 43 46 216
OXYCODONE HCL-ACETAMINOPHEN 76 0 S2 46 134
CLOPIDOGREL 76 49 46 53
SPIRONOLACTONE 76 36 46 42
OXYCONTIN 71 0 S2 50 133
SINGULAIR 70 41 51 106
NEXIUM 70 36 51 43
ZETIA 69 54 53 77
NIZATIDINE 68 32 54 231
AMITRIPTYLINE HCL 68 32 R 54 56
NYSTATIN-TRIAMCINOLONE 66 43 56 273
DIVALPROEX SODIUM 64 36 57 111
LOSARTAN-HYDROCHLOROTHIAZIDE 64 58 57 46
POLYETHYLENE GLYCOL 3350 63 47 59 32
METOCLOPRAMIDE HCL 63 17 59 125
TAMSULOSIN HCL 63 49 59 26
SERTRALINE HCL 62 48 62 20
GLIPIZIDE 60 43 63 82
CYMBALTA 60 0 63 49
TRIAMCINOLONE ACETONIDE 59 40 65 102
PLAVIX 59 39 65 86
VERAPAMIL ER 59 25 65 90
BENZTROPINE MESYLATE 58 45 R 68 163
MIRTAZAPINE 57 45 69 50
CARBIDOPA-LEVODOPA 57 45 69 69
FENTANYL 57 22 S2 69 45
PHENYTOIN SODIUM EXTENDED 57 22 69 121
FLURBIPROFEN 57 38 69 297
CHLORZOXAZONE 55 22 R 74 306
NAMENDA 55 55 74 35
LYRICA 54 30 76 92
CYCLOBENZAPRINE HCL 54 23 R 76 74
FLUTICASONE PROPIONATE 53 33 78 36
AZITHROMYCIN 53 33 78 70
OXYBUTYNIN CHLORIDE ER 53 47 78 114
CLONIDINE HCL 52 36 81 55
GLIMEPIRIDE 51 39 82 33
BUSPIRONE HCL 50 36 83 131
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 29, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.